IOL Chemicals Announces Investor Conference Call on 22 May 2026 for Q4 FY26 Results
IOL Chemicals and Pharmaceuticals Limited will hold an investor conference call on 22 May 2026 at 3:00 PM IST to discuss the financial results for the quarter and year ended 31 March 2026. Key management participants include Mr. Pardeep Kumar Khanna (CFO) and Mr. Abhay Raj Singh (Sr. VP & Company Secretary).
The announcement provides information about an upcoming investor call, which could be relevant for investors and analysts to understand the company's performance and future outlook.
The announcement is about scheduling an investor call, which is a routine activity. Hence, the sentiment is neutral.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has announced that it will hold an analyst/investor conference call on Friday, 22nd May 2026, at 3:00 PM IST to discuss the company's financial performance for the quarter and year ended 31st March 2026. The conference call details and invite have been attached to the announcement. The management participants include Mr. Pardeep Kumar Khanna (Chief Financial Officer), Mr. Abhay Raj Singh (Sr. VP & Company Secretary), Mr. Kushal Kumar Rana (Director Works), and Mr. Rakesh Mahajan (Finance Advisor & Strategic Head).
The conference call can be accessed via primary numbers +91 22 6280 1550 and +91 22 7115 8378. International toll-free numbers are also available for Hong Kong (800 964 448), Singapore (800 101 2045), USA (1866 746 2133), and UK (0808 101 1573). Interested participants are required to pre-register through the provided link. Ms. Prachi Ambre from MUFG Intime India Pvt. Ltd. is the contact person for RSVP, and she can be reached at +91 83559 85370 or prachi.ambre@in.mpms.mufg.com.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.